QIAGEN NV's ticker is QGENXXXX and the CUSIP is N72482107. A total of 180 filers reported holding QIAGEN NV in Q2 2015. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $236,000 | – | 9,378 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Exane Asset Management | 630,990 | $17,371,542,000 | 5.45% |
| Tikvah Management LLC | 369,425 | $10,137,000 | 5.29% |
| Hardman Johnston Global Advisors LLC | 3,786,208 | $103,894,000 | 4.73% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 300,000 | $8,232,000 | 4.50% |
| HealthCor Management, L.P. | 2,275,000 | $62,426,000 | 3.80% |
| Opus Point Partners Management, LLC | 110,565 | $3,034,000 | 1.70% |
| Douglas Lane & Associates, LLC | 1,847,676 | $50,700,000 | 1.35% |
| CRAMER ROSENTHAL MCGLYNN LLC | 2,854,629 | $78,331,000 | 1.20% |
| C M BIDWELL & ASSOCIATES LTD | 144,340 | $3,961,000 | 0.94% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,471,580 | $40,380,000 | 0.94% |